Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperoxia | 11 | 2024 | 59 | 2.110 |
Why?
|
| Thioredoxins | 4 | 2024 | 26 | 1.780 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 6 | 2008 | 29 | 1.020 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 487 | 0.840 |
Why?
|
| bcl-X Protein | 5 | 2009 | 34 | 0.780 |
Why?
|
| Lung | 5 | 2020 | 346 | 0.760 |
Why?
|
| Mitochondria | 2 | 2017 | 325 | 0.700 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2019 | 65 | 0.680 |
Why?
|
| Protein Interaction Mapping | 2 | 2016 | 34 | 0.670 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 151 | 0.650 |
Why?
|
| Oxidative Stress | 5 | 2024 | 619 | 0.630 |
Why?
|
| Peroxiredoxin III | 1 | 2017 | 4 | 0.560 |
Why?
|
| Oxidants | 1 | 2017 | 30 | 0.550 |
Why?
|
| Founder Effect | 1 | 2016 | 6 | 0.550 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 42 | 0.540 |
Why?
|
| Oxidation-Reduction | 5 | 2024 | 352 | 0.530 |
Why?
|
| Education, Professional | 1 | 2015 | 5 | 0.520 |
Why?
|
| Staff Development | 1 | 2015 | 7 | 0.520 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2016 | 52 | 0.510 |
Why?
|
| Laboratories | 1 | 2015 | 18 | 0.510 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 130 | 0.500 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 96 | 0.500 |
Why?
|
| Diabetes, Gestational | 1 | 2016 | 63 | 0.500 |
Why?
|
| Faculty | 1 | 2015 | 61 | 0.500 |
Why?
|
| Achievement | 1 | 2015 | 13 | 0.500 |
Why?
|
| Science | 1 | 2015 | 17 | 0.490 |
Why?
|
| Teaching | 1 | 2015 | 76 | 0.480 |
Why?
|
| Glucose | 1 | 2016 | 190 | 0.480 |
Why?
|
| Urban Population | 1 | 2015 | 70 | 0.480 |
Why?
|
| Peroxiredoxins | 1 | 2014 | 3 | 0.470 |
Why?
|
| Biomedical Research | 1 | 2015 | 93 | 0.470 |
Why?
|
| Carrier Proteins | 1 | 2016 | 245 | 0.470 |
Why?
|
| Rural Population | 1 | 2015 | 88 | 0.470 |
Why?
|
| Glutathione | 1 | 2014 | 68 | 0.460 |
Why?
|
| Apoptosis | 3 | 2017 | 737 | 0.460 |
Why?
|
| Cell Line, Tumor | 8 | 2017 | 1259 | 0.420 |
Why?
|
| T-Lymphocytes | 3 | 2004 | 274 | 0.410 |
Why?
|
| Oxygen | 4 | 2017 | 218 | 0.400 |
Why?
|
| Isothiocyanates | 2 | 2022 | 11 | 0.360 |
Why?
|
| Epithelial Cells | 2 | 2024 | 239 | 0.360 |
Why?
|
| Animals, Newborn | 5 | 2020 | 163 | 0.340 |
Why?
|
| Signal Transduction | 5 | 2022 | 1339 | 0.330 |
Why?
|
| Cell Survival | 5 | 2024 | 393 | 0.310 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 77 | 0.310 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 33 | 0.290 |
Why?
|
| Animals | 15 | 2024 | 9954 | 0.290 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 98 | 0.280 |
Why?
|
| Humans | 17 | 2024 | 26856 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 139 | 0.270 |
Why?
|
| Mice | 11 | 2024 | 4402 | 0.250 |
Why?
|
| Neurons | 2 | 2024 | 273 | 0.240 |
Why?
|
| Gene Deletion | 2 | 2020 | 115 | 0.240 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 656 | 0.240 |
Why?
|
| Chemokines, CC | 1 | 2004 | 3 | 0.230 |
Why?
|
| Autophagy | 1 | 2024 | 69 | 0.230 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2004 | 21 | 0.230 |
Why?
|
| Chemokine CCL2 | 1 | 2004 | 43 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 1474 | 0.220 |
Why?
|
| Biological Phenomena | 1 | 2022 | 4 | 0.210 |
Why?
|
| Respiratory Mucosa | 3 | 2024 | 51 | 0.200 |
Why?
|
| Pulmonary Alveoli | 2 | 2016 | 30 | 0.200 |
Why?
|
| Lung Diseases | 1 | 2022 | 41 | 0.200 |
Why?
|
| Heme Oxygenase-1 | 1 | 2020 | 36 | 0.170 |
Why?
|
| Rats | 3 | 2016 | 1536 | 0.170 |
Why?
|
| Benzene Derivatives | 1 | 2018 | 7 | 0.160 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 100 | 0.150 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 17 | 0.150 |
Why?
|
| Cell Death | 2 | 2008 | 110 | 0.150 |
Why?
|
| Models, Biological | 2 | 2019 | 446 | 0.150 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2017 | 3 | 0.140 |
Why?
|
| A549 Cells | 1 | 2017 | 16 | 0.140 |
Why?
|
| Gene Ontology | 1 | 2016 | 12 | 0.140 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 19 | 0.140 |
Why?
|
| Catalytic Domain | 1 | 2016 | 77 | 0.130 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 70 | 0.130 |
Why?
|
| Antioxidants | 1 | 2018 | 222 | 0.130 |
Why?
|
| Fetus | 1 | 2016 | 77 | 0.130 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 68 | 0.130 |
Why?
|
| Cell Division | 3 | 2006 | 153 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2016 | 173 | 0.130 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 107 | 0.130 |
Why?
|
| Hemodynamics | 1 | 2016 | 220 | 0.120 |
Why?
|
| South Dakota | 1 | 2015 | 20 | 0.120 |
Why?
|
| Educational Status | 1 | 2015 | 111 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 194 | 0.120 |
Why?
|
| Program Evaluation | 1 | 2015 | 162 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 537 | 0.120 |
Why?
|
| Buthionine Sulfoximine | 1 | 2014 | 1 | 0.120 |
Why?
|
| Career Choice | 1 | 2015 | 52 | 0.120 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2014 | 14 | 0.120 |
Why?
|
| Aging | 2 | 2020 | 954 | 0.120 |
Why?
|
| Protein Binding | 1 | 2016 | 631 | 0.120 |
Why?
|
| RNA Interference | 1 | 2014 | 135 | 0.110 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2014 | 35 | 0.110 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2014 | 61 | 0.110 |
Why?
|
| Interferon-gamma | 2 | 2004 | 102 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 2 | 2004 | 264 | 0.110 |
Why?
|
| Students | 1 | 2015 | 188 | 0.110 |
Why?
|
| Female | 6 | 2020 | 14462 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 624 | 0.100 |
Why?
|
| Eosinophil-Derived Neurotoxin | 1 | 2012 | 2 | 0.100 |
Why?
|
| Ribonucleases | 1 | 2012 | 9 | 0.100 |
Why?
|
| Pregnancy | 1 | 2016 | 1130 | 0.100 |
Why?
|
| Epithelium | 1 | 2012 | 39 | 0.100 |
Why?
|
| Influenza A virus | 1 | 2012 | 29 | 0.100 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2012 | 31 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2018 | 770 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2024 | 969 | 0.100 |
Why?
|
| Antioxidant Response Elements | 2 | 2022 | 5 | 0.090 |
Why?
|
| MCF-7 Cells | 2 | 2022 | 33 | 0.090 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2006 | 19 | 0.090 |
Why?
|
| Structure-Activity Relationship | 2 | 2022 | 200 | 0.090 |
Why?
|
| Transcription Factor CHOP | 1 | 2008 | 7 | 0.080 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cell Fractionation | 1 | 2008 | 18 | 0.080 |
Why?
|
| Cytoprotection | 1 | 2008 | 24 | 0.080 |
Why?
|
| Protein Sorting Signals | 1 | 2008 | 17 | 0.080 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 38 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 86 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 68 | 0.080 |
Why?
|
| Protein Transport | 1 | 2008 | 152 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2008 | 262 | 0.080 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 36 | 0.070 |
Why?
|
| Integrases | 2 | 2020 | 39 | 0.060 |
Why?
|
| Hypoxia | 1 | 2006 | 85 | 0.060 |
Why?
|
| DNA Repair Enzymes | 1 | 2005 | 9 | 0.060 |
Why?
|
| Male | 2 | 2020 | 12866 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 117 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 93 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 21 | 0.060 |
Why?
|
| Mutation | 1 | 2008 | 820 | 0.060 |
Why?
|
| Chemokine CCL21 | 1 | 2004 | 1 | 0.060 |
Why?
|
| Interleukin-4 | 1 | 2004 | 23 | 0.060 |
Why?
|
| Cell Line | 1 | 2006 | 671 | 0.060 |
Why?
|
| Trachea | 1 | 2024 | 25 | 0.060 |
Why?
|
| L-Selectin | 1 | 2004 | 11 | 0.060 |
Why?
|
| Sirolimus | 1 | 2024 | 68 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 75 | 0.060 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 88 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2024 | 115 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2004 | 95 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 184 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2003 | 11 | 0.050 |
Why?
|
| Vaccination | 1 | 2004 | 164 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2003 | 48 | 0.050 |
Why?
|
| Receptor, Notch3 | 1 | 2022 | 15 | 0.050 |
Why?
|
| Receptors, Notch | 1 | 2022 | 43 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 46 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2024 | 848 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 443 | 0.050 |
Why?
|
| Uteroglobin | 1 | 2020 | 5 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2020 | 36 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2009 | 781 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2020 | 61 | 0.040 |
Why?
|
| Lung Injury | 1 | 2020 | 31 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2009 | 645 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2019 | 22 | 0.040 |
Why?
|
| Genotype | 1 | 2020 | 443 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2019 | 36 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 101 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2018 | 239 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 588 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 405 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2009 | 503 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 323 | 0.030 |
Why?
|
| Electroporation | 1 | 2012 | 6 | 0.030 |
Why?
|
| Air | 1 | 2012 | 22 | 0.030 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2012 | 14 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2012 | 66 | 0.020 |
Why?
|
| Guanine | 1 | 2009 | 25 | 0.020 |
Why?
|
| G1 Phase | 1 | 2006 | 15 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 84 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 100 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2006 | 196 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 143 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 310 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2006 | 111 | 0.020 |
Why?
|
| Base Sequence | 1 | 2006 | 573 | 0.020 |
Why?
|
| Age Factors | 1 | 2006 | 716 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 284 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 395 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2003 | 23 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 339 | 0.010 |
Why?
|
| Chemokines | 1 | 2003 | 73 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 109 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 254 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 203 | 0.010 |
Why?
|